It has been reported that PAX3-Foxo1 can inhibit miR-221 and contribute to the pathogenesis of alveolar rhabdomyosarcoma, suggesting that Prx II regulates the expression of miR-221 through Foxo1 [21]. This evidence concerns the gene FOXO1 and rhabdomyosarcoma.